Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 6512

1.

Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?

Biglia N, Bounous VE, Sgro LG, D'Alonzo M, Pecchio S, Nappi RE.

Clin Breast Cancer. 2015 Jun 18. pii: S1526-8209(15)00121-4. doi: 10.1016/j.clbc.2015.06.005. [Epub ahead of print] Review.

PMID:
26198332
2.

A case of 17 alpha-hydroxylase deficiency.

Kim SM, Rhee JH.

Clin Exp Reprod Med. 2015 Jun;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. Epub 2015 Jun 30.

3.

What new therapeutic options exist for the relief of menopausal symptoms?

Raney EC.

JAAPA. 2015 Jul;28(7):14-6. doi: 10.1097/01.JAA.0000465229.36514.90.

PMID:
26107791
4.

A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.

Serati M, Bogani G, Di Dedda MC, Braghiroli A, Uccella S, Cromi A, Ghezzi F.

Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:48-50. doi: 10.1016/j.ejogrb.2015.05.026. Epub 2015 Jun 3.

PMID:
26070127
5.

Vaginal atrophy. Treatment options.

[No authors listed]

Mayo Clin Health Lett. 2014 Nov;32(11):7. No abstract available.

PMID:
26027044
6.

Urogenital prolapse--current methods of surgical treatment.

Tirnovanu MC, Luţuc MH, Mătrescu AC, Onofriescu M, Dalas E.

Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):147-53.

PMID:
25970958
7.

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women.

Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dubé R; other participating members of the VVA Prasterone Group.

Menopause. 2015 May 11. [Epub ahead of print]

PMID:
25968836
8.

A case of swyer syndrome associated with advanced gonadal dysgerminoma involving long survival.

Da Silva Rios S, Monteiro IC, Braz Dos Santos LG, Caldas NG, Chen AC, Chen JR, Silva HS.

Case Rep Oncol. 2015 Mar 31;8(1):179-84. doi: 10.1159/000381451. eCollection 2015 Jan-Apr.

9.

One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.

Portman D, Shulman L, Yeaw J, Zeng S, Uzoigwe C, Maamari R, Iyer NN.

Menopause. 2015 May 4. [Epub ahead of print]

PMID:
25944522
10.

[Effects of acupuncture on PI3K/Akt/mTOR signaling pathway in rats with premature ovarian failure].

Zhang Y, Yu B, Chen J, Zhao Z, Wang Jiali, Huang F, Lin Y, Wang M, Zhang Y, Wei B.

Zhongguo Zhen Jiu. 2015 Jan;35(1):53-8. Chinese.

PMID:
25906570
11.

Menopause and Hormone Replacement.

Warren MP, Shu AR, Dominguez JE.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Feb 25.

12.

Menopausal Symptoms: Comparative Effectiveness of Therapies [Internet].

Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Mar.

13.

Selecting anti-microbial treatment of aerobic vaginitis.

Donders GG, Ruban K, Bellen G.

Curr Infect Dis Rep. 2015 May;17(5):477. doi: 10.1007/s11908-015-0477-6.

PMID:
25896749
14.

Dehydroepiandrosterone for women in the peri- or postmenopausal phase.

Scheffers CS, Armstrong S, Cantineau AE, Farquhar C, Jordan V.

Cochrane Database Syst Rev. 2015 Jan 22;1:CD011066. doi: 10.1002/14651858.CD011066.pub2. Review.

PMID:
25879093
15.

Response to: A new approach to treatment of vulvovaginal atrophy.

Kim TH, Lee HH, Kim JM.

Maturitas. 2015 May;81(1):100. doi: 10.1016/j.maturitas.2015.02.008. Epub 2015 Mar 14. No abstract available.

PMID:
25843044
16.

Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.

Lester J, Pahouja G, Andersen B, Lustberg M.

J Pers Med. 2015 Mar 25;5(2):50-66. doi: 10.3390/jpm5020050.

17.

The effects of in utero bisphenol A exposure on reproductive capacity in several generations of mice.

Ziv-Gal A, Wang W, Zhou C, Flaws JA.

Toxicol Appl Pharmacol. 2015 May 1;284(3):354-62. doi: 10.1016/j.taap.2015.03.003. Epub 2015 Mar 11.

PMID:
25771130
18.

Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter.

Chen RY, Fan YM, Zhang Q, Liu S, Li Q, Ke GL, Li C, You Z.

J Immunol. 2015 Apr 15;194(8):4019-28. doi: 10.4049/jimmunol.1400806. Epub 2015 Mar 13.

PMID:
25769926
19.

Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.

Camp EA, Prehn AW, Shen J, Herbst AL, Strohsnitter WC, Hobday CD, Robboy SJ, Adam E.

J Womens Health (Larchmt). 2015 Apr;24(4):308-15. doi: 10.1089/jwh.2014.4930. Epub 2015 Mar 13.

PMID:
25768943
20.

DHEA replacement for postmenopausal women: placebo or panacea?

Eden JA.

Climacteric. 2015 Aug;18(4):439-40. doi: 10.3109/13697137.2015.1017706. Epub 2015 Mar 3.

PMID:
25731680
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk